| HS Code | 142746 |
| Product Name | CBZ-L-Hydroxyproline Methyl Ester |
| Cas Number | 6404-22-8 |
| Iupac Name | methyl (2S,4R)-1-(benzyloxycarbonyl)-4-hydroxypyrrolidine-2-carboxylate |
| Synonyms | Z-Hydroxyproline methyl ester; N-Cbz-L-hydroxyproline methyl ester; Z-Hyp-OMe |
| Molecular Formula | C14H17NO5 |
| Molecular Weight | 279.29 g/mol |
| Appearance | White to off-white crystalline powder |
| Melting Point | 98-102°C |
| Boiling Point | 363.1°C at 760 mmHg (predicted) |
| Density | 1.287 g/cm3 (predicted) |
| Optical Rotation | [α]20/D = -72° (c=1 in methanol) |
| Solubility | Soluble in methanol, ethanol, dichloromethane, and DMF; insoluble in water |
| Storage Condition | Store in a cool, dry place at 2-8°C; protect from light |
| Purity | ≥98% (by HPLC) |
| Smiles | COC(=O)[C@H]1C[C@H](O)CN1C(=O)OCC2=CC=CC=C2 |
As an accredited CBZ-L-Hydroxyproline Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged as a white crystalline powder in a sealed glass vial, quantity 25 g, stored dry and cool. |
| Container Loading (20′ FCL) | 20′ FCL loading of CBZ-L-Hydroxyproline Methyl Ester: packed in sealed drums on pallets, secured, dry and ventilated container. |
| Shipping | This product ships at ambient temperature in a sealed container, protected from moisture and light. It is not classified as dangerous goods for transport under standard shipping regulations when properly packaged. Standard courier handling is acceptable; keep away from excessive heat and verify integrity upon receipt. |
| Storage | Store CBZ-L-Hydroxyproline Methyl Ester sealed tightly in a cool, dry, dark place, preferably at –20°C. Protect from moisture, heat, and prolonged light exposure. Use an inert atmosphere if possible. Keep the container tightly closed and handle under dry conditions to prevent hydrolysis or degradation. |
| Shelf Life | Shelf life is typically 2-3 years when stored dry, cool, and protected from light and moisture. |
In cGMP peptide fragment condensation, CBZ-L-hydroxyproline methyl ester functions as a C-terminal building block requiring orthogonal protection of the pyrrolidine nitrogen and the carboxylic acid. The N-benzyloxycarbonyl group is removed by heterogeneous hydrogenation over 5% Pd/C or 10% Pd/C under 0.1–0.5 MPa hydrogen pressure in THF–methanol mixtures at 20–35 °C, while the methyl ester remains intact when the solvent system is maintained below pH 7.0. Production-scale hydrogenation vessels equipped with hollow-shaft gas dispersion and sintered-metal sparging show a mass-transfer-limited rate that shifts from kinetic control at laboratory scale to diffusion control beyond 500 L working volume; published data for this specific substrate in large-scale hydrogenators is limited, but technical data for analogous N-Cbz-proline methyl esters indicates 45–120 min post-uptake hold time to achieve 99.5% deprotection as determined by chiral HPLC. In subsequent condensation, the free amine is reacted with an activated pentafluorophenyl ester or TBTU/HOBt system; the methyl ester is retained to suppress racemization at the α-carbon. Typical charge ratios are 1.05–1.20 molar equivalents of the acyl component relative to the amine, with 1.30–1.50 molar equivalents of DIPEA in dichloromethane at 0–5 °C. Batch records governed by ICH Q7 Sections 7.4, 8.1, and 11.4 must include starting material identity, residual palladium analysis by ICP-MS after hydrogenolysis, and chiral purity ≥ 99.0% by validated HPLC. For U.S. FDA-registered intermediates, 21 CFR 210.3(b)(4) definitions and 211.28 personnel practice requirements apply. Terminal product types include dipeptide and tripeptide API intermediates, C-terminal hydroxyproline-containing peptidomimetics, and methyl ester-protected fragments for convergent solution-phase synthesis; operational boundaries include exclusion of free-amine storage at pH > 8.0 for more than 12 h, which otherwise increases methyl ester saponification to the free acid by 2–5% by HPLC area percent.
The synthesis of hydroxyproline-derived organocatalysts from CBZ-L-hydroxyproline methyl ester proceeds through reduction of the methyl ester to the primary alcohol followed by O-silylation. In non-GMP fine chemical production, the reduction is performed in a jacketed glass-lined reactor using sodium borohydride–calcium chloride in THF–ethanol at −5 to 0 °C; typical charge ratios are 1.0 mol substrate to 2.2–2.5 mol sodium borohydride and 1.1–1.2 mol calcium chloride. If ambient relative humidity exceeds 60%, the substrate is pre-dried under vacuum at 40 °C for 8 h before reduction. After quench with saturated ammonium chloride and extraction into ethyl acetate, the resulting N-Cbz-L-hydroxyprolinol is treated with trimethylsilyl chloride (1.2–1.5 molar equivalents) and imidazole (1.5–2.0 molar equivalents) in dimethylformamide at 0–5 °C. Process control focuses on water content below 0.1% by Karl Fischer titration to prevent silyl ether hydrolysis; typical isolated yields after column-free crystallization from heptane are 78–85%. Equipment includes a 50 L glass-lined reactor with anchor stirrer and a Hastelloy bottom valve to avoid chloride-induced pitting. Compliance for this non-API sector is typically limited to ISO 9001:2015 Clause 8.5.1 and REACH (EC No 1907/2006), with no pharmacopoeial monograph applied. Terminal product types include chiral organocatalysts for asymmetric aldol additions, Mannich reactions, and α-amination of aldehydes; incompatibility with residual water and protic solvents above 0.5% w/w is a known cause of batch rejection due to desilylation.
CBZ-L-hydroxyproline methyl ester enters collagen-derived research reagent synthesis through solution-phase segment condensation rather than solid-phase peptide synthesis because the N-Cbz group requires hydrogenolytic removal and the methyl ester provides a stable C-terminus during iterative chain elongation. Mixed anhydride activation with isobutyl chloroformate (1.0–1.05 molar equivalents) and N-methylmorpholine (1.0–1.1 molar equivalents) in dichloromethane at −15 to −20 °C is used to couple the N-deprotected amino component to N-Cbz-L-hydroxyproline methyl ester without detectable racemization. The methyl ester is retained through repeated fragment condensations to generate protected (Pro-Hyp-Gly)n intermediates; final deprotection of the N-Cbz group is conducted by hydrogenolysis over 10% Pd/C under 0.3 MPa hydrogen pressure. Terminal product types include triple-helical collagen peptide fragments for MMP-1 and MMP-13 activity assays and C-terminal methyl ester collagen standards for calibration. Compliance for research-use scales is limited to ISO 9001 Clause 8.5.4 preservation and REACH (EC) No 1907/2006; if the fragment is supplied to in vitro diagnostic developers, documentation typically follows ISO 13485:2016 Clause 7.5.8 label control. The primary operational boundary is avoidance of prolonged standing of deprotected amino methyl esters at ambient temperature, which promotes diketopiperazine formation and loss of chain-length fidelity.
| Scenario | Critical control measure | Typical numerical range | Applicable standard |
|---|---|---|---|
| Hydrogenolytic N-deprotection | pH, H₂ pressure, Pd/C ratio | 0.1–0.5 MPa, 20–35 °C, 10:1 w/w | ICH Q7 §7.4, §8.1 |
| O-Silylation | water content, TMSCl/imidazole ratio | H₂O ≤ 0.1%, TMSCl 1.2–1.5 eq | ISO 9001:2015 §8.5.1 |
| TEMPO oxidation | pH-stat set point, NaOCl feed time | pH 8.3–8.7, 60–90 min | REACH (EC) No 1907/2006 Annex II |
| Methyl ester hydrolysis | LiOH excess, quench pH | LiOH 1.05–1.10 eq, pH 2.5–3.0 | ICH Q7 §12.1–12.2 |
Oxidation of the 4-hydroxyl group in CBZ-L-hydroxyproline methyl ester to the corresponding 4-oxo derivative is carried out with TEMPO/NaOCl under buffered biphasic conditions in a glass-lined reactor fitted with a pH-stat. The reaction is exothermic, and the stoichiometric oxidant must be added over 60–90 min at 0–5 °C to avoid over-oxidation to ring-opened glutaric acid derivatives. Typical charge ratios are 1.0 mol substrate, 0.01–0.05 mol TEMPO, 0.1 mol KBr, and 1.05–1.20 mol NaOCl in aqueous NaHCO₃ buffer at pH 8.5. The pH-stat controls alkali addition to maintain 8.3–8.7, preventing formation of the N-hydroxy byproduct and preserving the methyl ester at the C-terminus. Following the reaction, excess hypochlorite is quenched with sodium sulfite and the product is extracted into ethyl acetate; isolated yields after silica-gel column purification are typically 72–80%. Terminal product types include CBZ-4-oxo-L-proline methyl ester and its derived 4,4-difluoro and 4-fluoro analogues used in medicinal chemistry structure-activity relationship studies; the downstream fluorination step with DAST is normally run in PTFE-lined vessels because of hydrogen fluoride release. Compliance includes REACH (EC) No 1907/2006 Annex II SDS documentation and ISO 9001:2015 Clause 8.5.1 production control; this oxidation is not conducted under GMP unless the resulting 4-oxo derivative is designated as a registered starting material. The upper pH boundary of 9.5 is critical, as base-catalyzed β-elimination of water from the 4-hydroxy group regenerates an α,β-unsaturated pyrroline that autocatalyzes further degradation.
Selective conversion of CBZ-L-hydroxyproline methyl ester to N-Cbz-L-hydroxyproline free acid is performed with aqueous lithium hydroxide in THF–water at 0–5 °C, using 1.05–1.10 molar equivalents of LiOH. Acidic hydrolysis is avoided because the protonated intermediate achieved with HCl at reflux temperature promotes partial carbamate cleavage and racemization at the α-carbon; published data for this specific configuration is limited, but in-process chiral HPLC typically shows 5–8% enantiomeric impurity if pH falls below 1.0 for more than 30 min. The LiOH process is run in a jacketed vessel with recirculating chiller to maintain 0–5 °C, and the reaction is quenched with 1.0 M citric acid to pH 2.5–3.0 before extraction into ethyl acetate. Terminal product types include N-Cbz-L-hydroxyproline free acid building blocks for subsequent amide coupling, and the isolated methyl ester hydrolysis step is a common in-process control point for peptide API intermediate campaigns. Compliance follows ICH Q7 Sections 12.1 and 12.2 if the free acid is used as an isolated intermediate in registered synthesis; otherwise ISO 9001 batch records apply. The main operational boundary is the upper LiOH excess: above 1.20 molar equivalents, hydroxide attack on the Cbz carbonyl becomes detectable as benzyl alcohol by GC headspace, reducing yield by 10–15% and complicating solvent recovery.
| Downstream sector | Primary standard | Clause / test method | Verification parameter |
|---|---|---|---|
| cGMP peptide API intermediate | ICH Q7; 21 CFR 210.3 | §11.4 process validation | residual Pd ≤ 10 ppm; chiral purity ≥ 99.0% |
| Organocatalyst manufacture | ISO 9001:2015 | Clause 8.5.1 | water ≤ 0.1%; achiral HPLC ≥ 98.0% |
| Collagen research reagents | ISO 13485:2016 for IVD pathway | Clause 7.5.8 | chain-length fidelity by LC-MS |
| 4-Oxo intermediate production | REACH (EC) No 1907/2006 | Annex II | residual solvent ≤ 5000 ppm |
Competitive CBZ-L-Hydroxyproline Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Typical release criterion | Analytical technique |
|---|---|---|
| Appearance | Colorless to pale yellow oil or low-melting solid | Visual inspection |
| Assay | ≥98.5% by HPLC area normalization | RP-HPLC-UV at 210 nm |
| Diastereomeric purity | ≥99.0% 2S,4R relative to 2S,4S | Chiral HPLC or 13C NMR |
| Water | ≤0.5% | Karl Fischer titration |
| Specific rotation | −50° to −60° (c=1, MeOH, 20 °C) | Polarimetry |
| Residual solvents | Meets ICH Q3C Class 2/3 limits | Headspace gas chromatography |
| Elemental impurities | ≤20 μg g−1 total heavy metals | ICP-MS |
| Storage | 2–8 °C under inert atmosphere | Controlled cold chain |
| Derivative | Primary deprotection | Stability in TFA/piperidine | Typical route implication |
|---|---|---|---|
| CBZ-L-Hydroxyproline Methyl Ester | H2/Pd-C or HBr/CH3COOH | Stable | Solution-phase orthogonality; semi-permanent amine protection |
| N-Boc-trans-4-hydroxy-L-proline methyl ester | Acidolysis | Cleaved by TFA | Acid-labile temporary amine protection |
| N-Fmoc-trans-4-hydroxy-L-proline methyl ester | Secondary amine | Cleaved by piperidine | Solid-phase Fmoc/tBu protocols |
| CBZ-L-Hydroxyproline | H2/Pd-C | Stable, but carboxyl-free | Direct coupling after activation |
| CBZ-cis-4-hydroxy-L-proline methyl ester | H2/Pd-C | Stable | Conformational probes; cis peptide bond mimics |